Startup valuation is three different questions wearing one name. What will an investor pay (negotiation)? What number satisfies the law (Companies Act, FEMA, tax – each with its own rulebook)? And what is the equity actually worth for ESOPs and internal decisions (allocation)? Different methods answer different questions: DCF and multiples for the certificates, backsolve and option-pricing for CCPS-heavy cap tables, scorecards and heuristics for angel-stage negotiation. This guide explains each method with the numbers Indian practice actually uses – and which statute accepts which signature.
DCF: the workhorse of Indian certificates
Project free cash flows for five years, discount them, add a terminal value. For startups the terminal value routinely carries 60–80%+ of the total – which is why the discount rate and terminal growth assumption decide the answer. Venture-stage discount rates run far above corporate WACC because they price failure risk: Indian valuers working from the standard venture literature use roughly 50–70% for seed, 40–60% for early stage, 30–50% for growth, and 20–35% pre-IPO, against 12–18% for a mature company. Worked skeleton: FCF of ₹1/2/3/4.5/6 crore over five years at a 25% discount rate gives ₹7.4 crore of explicit-period value; terminal value 6×1.05/(0.25–0.05) = ₹31.5 crore discounts to ₹10.3 crore; with ₹2.25 crore of cash, equity value ≈ ₹20 crore. The legal shield around DCF is now well built: tribunals have repeatedly held that projections are judged by what was reasonable on the valuation date, not by hindsight against actuals – Catwalk Worldwide (ITAT Mumbai, May 2026) deleted a ₹36.5 crore addition on exactly that principle, and the same logic protects FEMA certificates.
Market approaches: multiples and transactions
Comparable company multiples anchor to what the market pays for similar businesses: Indian practice uses EV/Revenue or EV/ARR of roughly 3–10x for SaaS (quality of retention and growth decides where in the band), GMV or revenue multiples for e-commerce, and P/E, P/B or EV/Revenue for fintech (P/B for lending books). Comparable transactions use actual Indian deal prints where they exist. Both suffer the same startup problem – the comparables are rarely comparable – so they usually corroborate a DCF rather than replace it. The clean exception is the backsolve: when the company itself just closed a round, that price is the best market evidence available, and the method built on it deserves its own section.
Backsolve and option-pricing: valuing equity under a preference stack
A ₹500 CCPS price does not mean the equity shares are worth ₹500 – the CCPS carries a liquidation preference and anti-dilution the equity does not. The option-pricing method (OPM) treats each class as a call option on total equity value, with breakpoints at the preference and conversion thresholds, and the backsolve runs it in reverse: find the total equity value at which the model prices the new CCPS at exactly what investors just paid. Worked sketch: a ₹50 crore Series A at ₹500/CCPS (headline post-money ₹250 crore) backsolves – with 60% volatility, a 3-year horizon – to total equity value near ₹175 crore; the common-share allocation lands around ₹310, and after a typical 25% discount for lack of marketability the equity FMV is ≈ ₹235, about 47% of the preferred price. That 30–60% common-to-preferred ratio is the practical norm – and it is the number that keeps ESOP exercise perquisites moderate, which is why backsolve-OPM is the standard for merchant-banker ESOP valuations under Rule 15. Its siblings – milestone analysis (value tied to discrete de-risking events) and PWERM (probability-weighted exit scenarios, best near an exit) – entered Indian statute briefly via the 2023 angel-tax rules; with those rules gone, all three survive as best practice for FEMA certificates and equity allocation rather than as tax mandates (see the valuation rules guide).
Angel-stage heuristics: honest rules of thumb
| Method | Mechanics in one line | Use |
|---|---|---|
| Scorecard | Start from the median pre-money of comparable regional seed deals; adjust by weighted factors (team ~30%, market ~25%, product ~15%, competition, traction…) | The most defensible angel heuristic |
| Berkus | Assign value per de-risking element – idea, prototype, team, relationships, early sales – India-adapted practice uses roughly ₹1–2 crore per element | Pre-revenue sanity cap |
| VC method | Exit value ÷ target return (10–30x, or a 40–60% IRR) – investment = pre-money | Shows the investor’s arithmetic |
| Risk-factor summation | Base value adjusted up/down across ~12 named risks | Cross-check |
None of these signs a certificate; all of them anchor the negotiation covered in the angel round guide. When an angel round needs paper – a priced CCPS issue – the registered valuer or CA behind the certificate will translate the negotiated number into a DCF or market-approach rationale.
Which statute accepts which method (and whose signature)
| Purpose | Method regime | Signature |
|---|---|---|
| FEMA Rule 21 certificate | Any internationally accepted methodology, arm’s length – DCF dominates | CA / merchant banker / cost accountant |
| Companies Act preferential-issue price | Registered valuer’s professional judgment (ICAI Valuation Standards 101–303 for RVO members) | Registered valuer only |
| s.92 / s.79 income-tax FMV | Rule 57 NAV formula only for unquoted equity; open-market for CCPS/other securities | Computational; MB or accountant support |
| ESOP perquisite (Rule 15) | Merchant banker’s FMV – backsolve-OPM standard | Merchant banker only, 180-day window |
| Cross-border swaps (Rule 9A) | As certified | Merchant banker / overseas investment banker only |
Need the right number for the right statute?
My Cloud Accountant coordinates DCF certificates, registered-valuer reports and merchant-banker ESOP valuations – consistent assumptions, correct signatures, one file.
Talk to an expertFrequently Asked Questions
Which valuation method gives the highest number?
Wrong question – methods answer different purposes. For negotiation, comparables in a hot sector run highest; DCF is as high as its assumptions; NAV is almost always lowest for a startup. Investors triangulate; certificates must justify, not maximise.
Is a valuation done for the last round reusable for this round?
Rarely. FEMA practice expects certificates within ~90 days of the transaction; the ESOP rule allows a 180-day window from its specified date; and a new round’s terms change the backsolve inputs entirely. Budget for fresh reports per event – they are cheap against the risks they retire.
Why is our ESOP valuation so much lower than our round price?
Because it should be: the round price buys CCPS with a liquidation preference and other protections; the ESOP values plain equity under that stack, discounted further for non-marketability. A 30–60% ratio of equity FMV to preferred price is normal – and it is your employees’ tax advantage, not an error.
What happens if the projections in our DCF turn out wrong?
Nothing, if they were honest when made – tribunals consistently refuse to test valuation-date projections against later actuals (Catwalk Worldwide, ITAT Mumbai 2026, is the latest). What sinks valuations is internal inconsistency – projections contradicting the board’s own contemporaneous documents. Keep the assumptions file.
Last reviewed: August 2026. ICAI Valuation Standards 101–303; Income-tax Rules 2026 (Rules 15, 56–57); FEM (NDI) Rules 2019 Rule 21; discount-rate and multiple ranges reflect published venture-valuation literature and Indian market practice – engagement-specific numbers vary.